Xoma argued Janssen breached the contract Xoma had with the third-party pharmaceutical company, as well as the contract the ...

In 2014, Janssen handed over $35 million, with a promise of up to $900 million more, to partner with Geron on its telomerase inhibitor imetelstat. Now, Janssen is pulling out of the deal after a ...

Although steadily employed throughout the 1950s and early 1960s, David Janssen saw his status as an actor and a star rise significantly in 1963 when he made his debut in the television series The ...

The European Medicines Agency has approved the continuous manufacturing production of the HIV drug Prezista (darunavir) by Janssen Pharmaceuticals, a unit of Johnson & Johnson. Production of the ...

In this interview, Nauman Shah, Global Head, Janssen Business Development, discusses the new era of collaboration and the outlook for pharma business development that will lead to future innovation.

Beleaguered car dealer and poker pro George Janssen is facing federal bank fraud charges (Getty Images for World Series of) The latest headlines from our reporters across the US sent straight to your ...

Janssen, a Johnson & Johnson company, has announced positive topline results from its Phase 2b FRONTIER 1 trial evaluating JNJ-2113, a novel first-and-only oral interleukin-23 receptor antagonist ...

Tremendous strides in the development and delivery of prostate cancer treatments have been made by researchers around the world — and new advances are on the horizon. As the second-most common cancer ...

Johnson & Johnson’s Janssen unit has filed for approval of its multiple myeloma CAR-T ciltacabtagene autoleucel in Europe, chasing after a rival therapy from Bristol-Myers Squibb. The BCMA-targeting ...

Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said. By Apoorva ...